Suppr超能文献

[根据世界卫生组织最新分类标准统计的山西省淋巴瘤亚型患病率]

[Prevalence of lymphoma subtypes in Shanxi according to latest WHO classification].

作者信息

Wang Jin-fen, Wang Yun-zhong, Chen Zhen-wen, Taylor R Clive

机构信息

Department of Pathology, Shanxi Tumor Hospital, Taiyuan 030013, China.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2006 Apr;35(4):218-23.

Abstract

OBJECTIVE

To analyze the prevalence of lymphoma subtypes in Shanxi according to the latest World Health Organization (WHO) classification, and to compare the figures with those in other parts of the world.

METHODS

The hematoxylin and eosin-stained sections of 447 lymphoma cases from the archive files of Shanxi Tumor Hospital were reviewed. Immunohistochemical study was performed using a panel of antibodies, including ALK1, bcl-6, CD (1a, 3, 4, 5, 7, 8, 10, 15, 20, 23, 30, 43, 56, 68, 79a and 99), cyclin D1, EMA, IgD, kappa, lambda, LMP1, PAX5, TdT and Vs38C. In addition, in-situ hybridization for Epstein-Barr virus-encoded RNA (EBER) was carried out. All cases were then reclassified according to the latest WHO classification of lymphoma.

RESULTS

Of the 447 cases studied, 385 cases (86.1%) were confirmed to be non-Hodgkin lymphoma (NHL), while 62 cases (13.9%) belonged to classic Hodgkin lymphoma (HL). Of the NHL cases, 68.3% were of B-cell lineage and 30.6% were of T and/or NK-cell lineage. Histiocytic neoplasm accounted for only 0.8% (3 cases). As for the subtyping of NHL, diffuse large B-cell lymphoma was commonest (35.1%), followed by peripheral T-cell lymphoma, NOS (12.0%), extranodal marginal zone B-cell lymphoma (MALT lymphoma) (11.7%), follicular lymphoma (8.6%), T-lymphoblastic lymphoma (7.0%), anaplastic large cell lymphoma (4.2%), B-small lymphocytic lymphoma (3.6%) and mantle cell lymphoma (2.6%). Amongst the 263 cases of B-cell lymphoma, 105 cases (39.9%) expressed immunoglobulin light chain (kappa in 52 cases and lambda in 53 cases) in paraffin sections. Regarding markers for EB virus infection, 14 cases of the B-cell lymphoma gave positive findings with both EBER in-situ hybridization and LMP-1 immunohistochemistry, while 6 of the T/NK-cell lymphoma expressed LMP-1 and 19 showed positive signals for EBER. In NHL, there was discordance in EBER in-situ hybridization and LMP-1 immunohistochemical results. As for HL, EB virus positivity was noted in 37 of the 62 cases (59.7%), including 7 cases of lymphocyte-rich HL, 11 cases of mixed cellularity HL and 19 cases of nodular sclerosis HL. In classic HL, there was complete concordance of results by both EBER in-situ hybridization and LMP-1 immunohistochemistry.

CONCLUSIONS

The prevalence of diffuse large B-cell lymphoma in Shanxi is similar to that in America, Australia, Japan and Korea. The incidence of follicular lymphoma however is much lower than America and Australia.

摘要

目的

根据世界卫生组织(WHO)最新分类分析山西淋巴瘤亚型的患病率,并与世界其他地区的数据进行比较。

方法

回顾山西肿瘤医院存档文件中447例淋巴瘤病例的苏木精-伊红染色切片。使用一组抗体进行免疫组织化学研究,包括ALK1、bcl-6、CD(1a、3、4、5、7、8、10、15、20、23、30、43、56、68、79a和99)、细胞周期蛋白D1、EMA、IgD、kappa、lambda、LMP1、PAX5、TdT和Vs38C。此外,进行了爱泼斯坦-巴尔病毒编码RNA(EBER)的原位杂交。然后根据WHO最新的淋巴瘤分类对所有病例进行重新分类。

结果

在研究的447例病例中,385例(86.1%)确诊为非霍奇金淋巴瘤(NHL),而62例(13.9%)属于经典霍奇金淋巴瘤(HL)。在NHL病例中,68.3%为B细胞系,30.6%为T和/或NK细胞系。组织细胞肿瘤仅占0.8%(3例)。至于NHL的亚型,弥漫性大B细胞淋巴瘤最为常见(35.1%),其次是外周T细胞淋巴瘤,NOS(12.0%),结外边缘区B细胞淋巴瘤(MALT淋巴瘤)(11.7%),滤泡性淋巴瘤(8.6%),T淋巴母细胞淋巴瘤(7.0%),间变性大细胞淋巴瘤(4.2%),B小淋巴细胞淋巴瘤(3.6%)和套细胞淋巴瘤(2.6%)。在263例B细胞淋巴瘤中,105例(39.9%)在石蜡切片中表达免疫球蛋白轻链(kappa 52例,lambda 53例)。关于EB病毒感染标志物,14例B细胞淋巴瘤在EBER原位杂交和LMP-1免疫组织化学中均呈阳性结果,而6例T/NK细胞淋巴瘤表达LMP-1,19例显示EBER阳性信号。在NHL中,EBER原位杂交和LMP-1免疫组织化学结果存在不一致。至于HL,62例中有37例(59.7%)EB病毒阳性,包括7例富于淋巴细胞型HL、11例混合细胞型HL和19例结节硬化型HL。在经典HL中,EBER原位杂交和LMP-1免疫组织化学结果完全一致。

结论

山西弥漫性大B细胞淋巴瘤的患病率与美国、澳大利亚、日本和韩国相似。然而,滤泡性淋巴瘤的发病率远低于美国和澳大利亚。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验